Genetic Association of Drug Response to Erlotinib in Chinese Advanced Non-small Cell Lung Cancer Patients

The efficacy of erlotinib treatment for advanced non-small cell lung cancer (NSCLC) is due to its action as an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI). Patients treated with erlotinib experience different drug responses. The effect of germline mutations on therapeutic r...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Cong Wang (Yazar), Fang Chen (Yazar), Yichen Liu (Yazar), Qingqing Xu (Yazar), Liang Guo (Yazar), Xiaoqing Zhang (Yazar), Yunfeng Ruan (Yazar), Ye Shi (Yazar), Lu Shen (Yazar), Mo Li (Yazar), Huihui Du (Yazar), Xiaofang Sun (Yazar), Jingsong Ma (Yazar), Lin He (Yazar), Shengying Qin (Yazar)
Materyal Türü: Kitap
Baskı/Yayın Bilgisi: Frontiers Media S.A., 2018-04-01T00:00:00Z.
Konular:
Online Erişim:Connect to this object online.
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Internet

Connect to this object online.

3rd Floor Main Library

Detaylı Erişim Bilgileri 3rd Floor Main Library
Yer Numarası: A1234.567
Kopya Bilgisi 1 Kütüphanede